Pu Lin Johnson Bio - Pharmaceutical

Pu Lin Johnson Bio-Pharmaceutical Co., Ltd. (hereinafter referred to as "Pu Lin Johnson") is a third-tier controlled subsidiary of the company, established by the wholly-owned subsidiary Huahai (US) International Co., Ltd. (hereinafter referred to as "Huahai US") in October 2009 in the Cayman Islands, with a registered capital of USD 50,000.00 and a total issued share capital of 363 million shares. The company mainly engages in the research, production, and sales of generic drugs in the US market.